Undoctored vault view

Providing antiviral medicine for COVID-19 to eligible people will become the key focus of primary and community pharmacy care from 1st October, ensuring people most at risk of serious outcomes from the virus receive the support they need.

A second person has been confirmed with measles in Tāmaki Makaurau in the last seven days. This case is unrelated to the measles case notified last week but is also linked to recent overseas travel. 

As pharmacists around the world come together to celebrate World Pharmacists Day, the Society of Hospital Pharmacists of Australia (SHPA) is announcing a landmark recognition program that will transform pharmacy practice in Australia and New Zealand.

Labour will fund more medicines for more New Zealanders by investing over $1 billion of new funding into Pharmac if re-elected, Chris Hipkins announced today.

Two community pharmacist groups are expressing concern that the National Party may seek to open up pharmacy ownership to big business if in government after 14 October, following conversations with political parties.

Approval for pholcodine (a medicine found in some cough syrups and lozenges) to be sold in New Zealand will be withdrawn on 12 January 2024.

Te Pātaka Whaioranga – Pharmac is widening access to COVID-19 antivirals to people who are vulnerable to severe infection from COVID-19, including those with disabilities and with one or more severe health conditions

While the new vaping laws are a step in the right direction, Government's efforts continue to fall short in addressing the escalating vaping crisis among our youth

Te Whatu Ora is continuing efforts to try to reach a settlement with the Association of Salaried Medical Specialists (ASMS)